Improving Drug Options for Colorectal Cancer Patients

Improving Drug Options for Colorectal Cancer Patients Patients with colorectal cancer were among the first to receive targeted therapies. These drugs aim to block the cancer-causing proteins that trigger out-of-control cell growth while sparing healthy tissues. But some patients are not eligible for these treatments because they have cancer-promoting mutations

Antipsychotic Drugs May Increase Risk of Breast Cancer

Antipsychotic Drugs May Increase Risk of Breast Cancer Tracking medications provided to over a half million U.S. women, researchers at Washington University School of Medicine in St. Louis have found that many commonly prescribed older antipsychotic medications, and some newer ones, are associated with a significant increase in risk of

Cancer Moonshot Grant Funds Research Into Reducing Health Disparities

Cancer Moonshot Grant Funds Research Into Reducing Health Disparities Washington University School of Medicine in St. Louis has received a $17 million grant from the National Institutes of Health (NIH) to address disparities in cancer research, treatment and outcomes in underrepresented populations. The research, funded through the National Cancer Institute’s

Uncovering How Injury to the Pancreas Impacts Cancer Formation

Uncovering How Injury to the Pancreas Impacts Cancer Formation Scientists at the Salk Institute and Vanderbilt University School of Medicine Basic Sciences have found that cells in the pancreas form new cell types to mitigate injury, but are then susceptible to cancerous mutations. Read more...

Go to Top